U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
NVX-COV2373
UK9AK2IN1P
Other
General
Record Details
Names
5
Identifiers
6
Concept Definition
Relationships
1
Active Moiety
1
NVX-COV2373
UK9AK2IN1P
Other
General
Approval Year
Unknown
149,124
Record Details
Substance Class
Concept
Record UNII
UK9AK2IN1P
Record Status
Validated (UNII)
Record Version
35
34
33
32
31
30
29
28
27
26
25
24
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
Names
5
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
SARS-COV-2 SPIKE GLYCOPROTEIN VACCINE ANTIGEN NVX-COV2373
Preferred Name
English
NVX-COV2373
Code
English
TAK-019
Code
English
NVX-CoV 2372
Common Name
English
COVOVAX VACCINE PROTEIN ANTIGEN
Common Name
English
Showing 1 to 5 of 5 entries
Previous
1
Next
Identifiers
6
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
SMS_ID
300000017644
PRIMARY
NCI_THESAURUS
C172755
PRIMARY
FDA UNII
UK9AK2IN1P
PRIMARY
DAILYMED
UK9AK2IN1P
PRIMARY
CAS
2972498-09-0
NO STRUCTURE GIVEN
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Concept Definition
This is a non-substance concept
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
B6L4N5Z4GH
SARS-COV2
TARGET ORGANISM->VACCINE ANTIGEN
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
UK9AK2IN1P
NVX-COV2373
ACTIVE MOIETY
Amount:
Showing 1 to 1 of 1 entries
Previous
1
Next
This is a non-substance concept
